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A B S T R A C T
Simple sequence repeat (SSRs) of DNA are subject to high rates of mutation and are important mediators
of adaptation inHaemophilus inﬂuenzae. Previous studies of the Rd KW20 genome identiﬁed the primacy
of tetranucleotide SSRs in mediating phase variation (the rapid reversible switching of gene expression)
of surface exposed structures such as lipopolysaccharide. The recent sequencing of the genomes of
multiple strains of H. inﬂuenzae allowed the comparison of the SSRs (repeat units of one to nine
nucleotides in length) in detail across four complete H. inﬂuenzae genomes and then comparison with a
further 12 genomes when they became available. The SSR loci were broadly classiﬁed into three groups:
(1) those that did not vary; (2) those for which some variation between strains was observed but this
could not be linked to variation of gene expression; and (3) those that both varied and were located in
regions consistent with mediating phase variable gene expression. Comparative analysis of 988 SSR
associated loci conﬁrmed that tetranucleotide repeats were the major mediators of phase variation and
extended the repertoire of known tetranucleotide SSR loci by identifying ten previously uncharacterised
tetranucleotide SSR loci with the potential to mediate phase variation which were unequally distributed
across the H. inﬂuenzae pan-genome. Further, analysis of non-tetranucleotide SSR in the 16 strains
revealed a number of mononucleotide, dinucleotide, pentanucleotide, heptanucleotide, and octanucleo-
tide SSRs which were consistent with these tracts mediating phase variation. This study substantiates
previous ﬁndings as to the important role that tetranucleotide SSRs play in H. inﬂuenzae biology. Two
Brazilian isolates showed the most variation in their complement of SSRs suggesting the possibility of
geographic and phenotypic inﬂuences on SSR distribution.
 2008 Elsevier B.V. Open access under CC BY license.1. Introduction
Haemophilus inﬂuenzae (Hi), a common commensal bacterium
of the upper respiratory tract of humans, is an important cause of
diseases that include otitis media, pneumonia, meningitis, and
septicaemia. The genome sequence of Hi strain Rd KW20, the
ﬁrst completed for a free-living organism, revealed a high
prevalence of simple sequence repeats (SSRs) (Fleischmann
et al., 1995; Hood et al., 1996b). SSRs are usually deﬁned as
direct, perfect DNA repeats consisting of repeat units (the
smallest repeating DNA motif of the SSR) of between one and
nine nucleotides in length. In many organisms, taking into
account the nucleotide sequence composition of their respective
genomes, SSRs are found less frequently than predicted (Mra´zek
et al., 2007). SSRs are hypermutable (e.g. tetranucleotide SSRs
lose and gain units at a rate of 1  104 per generation (De Bolle
et al., 2000) compared with a basal mutation rate of approxi-
mately 1  109) and, therefore, it has been suggested that
their decreased prevalence reﬂects natural selection because the* Corresponding author. Fax: +44 1865 222626.
E-mail address: peter.power@paediatrics.ox.ac.uk (P.M. Power).
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doi:10.1016/j.meegid.2008.11.006higher rates of mutation of these loci would be more often
detrimental to ﬁtness than beneﬁcial. However, in some
prokaryotes, predominantly host-adapted organisms, some SSRs
are found in greater numbers than would be expected by chance
(Mra´zek et al., 2007). Analysis of SSRs in the Hi strain Rd
KW20 genome revealed that long tracts of tetranucleotides
were over-represented (Hood et al., 1996b). A striking feature of
these tetranucleotide SSRs is their frequent association with
genes whose functions are associated with microbial-host
interactions relevant to commensal and virulence behaviour
(Hood et al., 1996b).
SSRs can be located in promoter regions or within open reading
frames and changes in their length can result in the random, high
frequency, reversible loss, gain or modulation of gene expression
(phase variation). Since these regions of localised hypermutation,
often termed ‘contingency loci’, can each independently result in
altered gene expression, a repertoire of phenotypic variants is
generated (Moxon et al., 2006). Through selection of these variants,
the adaptation of the bacterial population to changes in the host
environment is facilitated. It has been suggested that this strategy
has particular survival value when bacterial populations are
subjected to periodic selection during transmission between
genetically distinct hosts (Wolf et al., 2005).
Table 1
Characteristics of genome sequences used in this study.
Strain GenBank accession
number
Source strain informationa Referenceb
Four genome study
Rd KW20 NC_000907 Acapsulate serotype d, nasopharynx, USA Fleischmann et al. (1995)
86-028NP NC_007146 NTHi, isolated from a child with otitis media, USA Harrison et al. (2005)
R2846c NTHi, middle ear ﬂuid of a child with acute otitis
media
http://www.genome.washington.edu/UWGC/Hinf/
index.cfm (strain 12, Barenkamp and Leininger,
1992)
R2866c NTHi, blood of a child with meningitis http://www.genome.washington.edu/UWGC/Hinf/
index.cfm (Int1, Nizet et al., 1996)
Twelve genome study
PittGG NC_009567 NTHi, external ear discharge from otorrhea, USA Hogg et al. (2007)
PittEE NC_009566 NTHi, chronic otitis media with effusion, USA Hogg et al. (2007)
R3021d NZ_AAZJ00000000 NTHi, nasopharynx of a healthy individual, USA Hogg et al. (2007)
PittIId NZ_AAZI00000000 NTHi, chronic otitis media with effusion, USA Hogg et al. (2007)
PittHHd NZ_AAZH00000000 NTHi, chronic otitis media with effusion, USA Hogg et al. (2007)
PittAAe NZ_AAZG00000000 NTHi, middle ear effusion of a child with chronic
otitis media, USA
Hogg et al. (2007)
3655d NZ_AAZF00000000 NTHi, middle ear effusion of a child inMissouri with
acute otitis media, USA
Hogg et al. (2007)
22.4.21d NZ_AAZE00000000 NTHi, nasopharynx of a healthy individual, USA Hogg et al. (2007)
22.1.21d NZ_AAZD00000000 NTHi, nasopharynx of a healthy individual, USA Hogg et al. (2007)
F3031d,e NZ_AAD-
O00000000
Hi biogroup aegyptius, Brazilian purpuric fever,
Brazil
http://www.sanger.ac.uk/sequencing/
Haemophilus/inﬂuenzae/F3031/
F3043d,e NZ_AADP00000000 Hi biogroup aegyptius, purulent conjunctivitis,
Brazil
http://www.sanger.ac.uk/sequencing/
Haemophilus/inﬂuenzae/F3043/
10810 Serotype b, meningitis isolate, UK http://www.sanger.ac.uk/Projects/H_inﬂuenzae/
The four strains for which the complete genome sequences were available at the commencement of this study are listed in the upper portion of the table; the further twelve
strains for which full or partial sequences were later acquired are detailed in the lower portion.
a Lists the serotype, the site of isolation and associated clinical features, and country of isolation.
b Where there is no appropriate publication available, the www address from which sequences were obtained is listed.
c The complete genome sequences for these strains were made available to us courtesy of Dr Alice Erwin.
d Incomplete genomes.
e The genome sequences for these strains were made available to us courtesy of Prof. Simon Kroll and the Welcome Trust Sanger Sequencing Centre.
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same species has revealed that the genomic sequence of a
particular strain may not reﬂect the diversity and variety of the
entire species. The term ‘pan-genome’ has been used to describe
the superset of genes of a species (Tettelin et al., 2005). The
characterisation of a pan-genome describes the core (genes
contained in all genomes of a species) and dispensable genes
(those genes absent from one or more strains or unique to each
strain) of a species. We suggest that the concept of a pan-genome
should also include explicit recognition of differences in gene
sequence, organisation and variation that may better describe the
adaptive and evolutionary potential of the species (Caporale,
2006). In this study, we have sought to identify the potential
repertoire of variation mediated by SSRs in the currently available
Hi pan-genome.
Prior to this study, our understanding of SSRs in Hi has been
predominantly based on analysis of the strain Rd KW20 genome
sequence. Whilst selective studies of other Hi strains have
provided some evidence to suggest variation in the number,
location and nature of the SSRs compared to that seen in the Rd
KW20 genome (Fox et al., 2005; van Belkum et al., 1997), the
recent availability of a number of completely sequenced Hi
genomes has provided us with the opportunity for a much more
extensive analysis of SSRs in Hi.
We describe in detail 223 SSRs identiﬁed in the four complete
genome sequences of strains RdKW20, 86-028NP, R2846 and
R2866 plus 765 SSRs identiﬁed in the complete or partial genome
sequences of a further 12 Hi strains. Previous reports of SSRs in Hi
have been predominantly of tetranucleotide repeats. From these
16 genomes we describe 199 tetranucleotide SSRs in 28 different
loci including 10 which have not previously been described.
However, we have also identiﬁed a number of mononucleotide,
dinucleotide, pentanucleotide, heptanucleotide, and octanucleo-tide SSRs with a putative role in phase variable gene regulation. A
preponderance of the novel SSRs identiﬁed occur in only two
strains, F3031 and F3034 of the Hi biogroup aegyptius, suggesting
that the distribution of SSRs across the Hi pan-genome may be
linked with geographic and phenotypic proﬁles.
2. Materials and methods
The four Hi genome sequences that were available at the
commencement of this study formed the basis of the Hi four
genome study. Details of these genomes are given in Table 1. A list
of SSRs with repeat unit lengths of between one and nine
nucleotides, and a number of repeat unit iterations above an
empirically determined threshold value (see below) was compiled
for each of these genomes using a PERL script that we have
developed and have called HiSSRﬁnder. The results from HiSSR-
ﬁnderwere used to generate an annotated EMBL ﬁle for each of the
genomes which then allowed manual analysis and curation of the
SSRs identiﬁed in each genome using the Artemis and ACT genome
viewing, annotation and comparison programs (Rutherford et al.,
2000). Each SSR was manually evaluated with regards to its
position relative to open reading frames (ORFs), whether an
equivalent SSR was present or not in the other three strains and
whether there was any variation in the SSR between strains (see
Supplementary Table 1).
The threshold values, i.e. the minimum number of repeat units
required to be present in an uninterrupted tandem arrangement
within a genome in order for that sequence to be counted as an SSR
and included in further analysis, was determined for each different
length of repeat unit from a comparison of the number of SSRs of
different lengths and the frequency of polymorphisms between the
four genomes (see Section 3 and Table 2). The thresholds
determined in this way for this study were as follows: 1 (repeat
Table 2
Determination of the minimum threshold for SSR detection in H. inﬂuenzae genome sequences, with reference to strain Rd KW20.
Repeat unit length Threshold
valuea
Maximum
expected lengthb
Number of SSRs in Strain Rd-KW20 Genome identiﬁed usingc
No. Preﬁx Threshold value 1 Threshold value Threshold value +1
1 Mono 9 13 163 18 2
2 Di 5 5 88 5 0
3 Tri 4 4 814 13 1
4 Tetra 3 3 38 12 12
5 Penta 3 2 1676 5 2
6 Hexa 3 ND 940 5 1
7 Hepta 3 ND 126 0 0
8 Octa 3 ND 45 0 0
9 Nona 3 ND 34 2 1
3924 60 19
This table sets out the minimum number of repeat units (threshold value) for the identiﬁcation of SSRs of each repeat unit length used in this study. ND: not determined.
a The threshold value is theminimumnumber of repeat units required to be present in an uninterrupted tandem arrangement in order for that sequence to be deﬁned as an
SSR.
b Maximum expected length is the maximum number of repeat units of each designated length that would be expected to occur in the Rd KW20 genome as predicted by
hidden Markov model analysis (Paul Swift, personal communication).
c The values in columns Threshold value1 and Threshold value +1, show the number of SSR identiﬁed of eachmotif length in the Rd KW20 genome if the threshold value is
decreased or increased by one unit, respectively.
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>2, 5, >2; 6, >2; 7, >2; 8, >2 and 9, >2.
A database, named SSR_Hi_4G, was constructed to contain the
nucleotide sequences of each of the tetranucleotide SSR, together
with their 500 bp upstream and downstream ﬂanking sequences,
identiﬁed in the four genome study. This database was assembled
using the formatdb program (SSR_Hi_4G is available at http://
users.ox.ac.uk/oxmicro/ssrblast.html, formatdb program is avail-
able at http://www.ncbi.nlm.nih.gov/blast/download.shtml).
A second collection ofHi genomes (herein termed the further 12
genome study) was then examined using the information from the
initial four genome survey to guide analysis. Details of these
additional genomes are given in Table 1. The SSRs in these genomes
were identiﬁed using the HiSSRﬁnder script as described above. In
order to determine which of the tetranucleotide SSRs identiﬁed
in the 12 further genome sequences were equivalent to the
tetranucleotide SSRs previously identiﬁed in the four genome
study, each was compared to the SSR_Hi_4G database using the
BLASTN program. Data and boxplot analysis of SSR data was
performed using the R statistical package (http://www.r-projec-
t.org/) and Microsoft Excel. Transmembrane helicies were pre-
dicted using the TMHMMweb server v2.0 (http://www.cbs.dtu.dk/
services/http://www.cbs.dtu.dk/services/TMHMM; Moxon et al.,
2006; Sonnhammer et al., 1998).
3. Results
3.1. Determination of threshold values used to identify SSRs in this
study
Previous studies on Hi have described the SSRs present within
the genome of strain Rd KW20 (Hood et al., 1996b). Our aimwas to
extend the analysis of SSRs by comprehensively investigating the
repertoire present in the four complete Hi genome sequences that
were available for different strains of Hi at the commencement of
this study (Four Genome Analysis; see Table 1). In this study, SSRs
are deﬁned as tandem repeats of a repeat unit that consists of
between one and nine nucleotides. In order to attain maximum
sensitivity for the detection of SSRs the threshold values (see
Section 2) were set as low as practically possible. Our rationale for
adopting threshold values is described in Table 2, which shows the
number of SSRs identiﬁed in the genome of strain Rd KW20 at the
threshold values adopted and also the number of SSRs that would
have been included in the subsequent analysis if the threshold
value had been set one unit higher or lower for each repeat unitlength. It can be seen from Table 2 that, for all but the tetranu-
cleotide SSRs, increasing the threshold value by one substantially
decreased the number of SSRs detected and resulted in a total of
only 19 SSRs being identiﬁed in the Rd KW20 genome. In contrast,
decreasing the threshold by one resulted in a large number of SSRs
being identiﬁed which would be impractical for manual analysis
(3924 in strain Rd KW20). At the adopted threshold values, 60 SSRs
were identiﬁed in strain Rd KW20. The thresholds used in this
study for all repeat unit lengths included at least all of the
statistically unexpected SSRs determined by hiddenMarkovmodel
analysis of the Hi genomes (see Table 2; Paul Swift, Oxford,
personal communication). This further substantiates the threshold
values chosen as being permissive for having a high degree of
sensitivity in identifying SSRs with potential roles in mediating
phase variation. Additionally, if SSRs were found to be above
threshold in at least one genome the corresponding regions in the
other genomes were also characterised.
A total of 223 SSRs were identiﬁed in the four genome
sequences when the threshold values described in Table 2 were
applied and these 223 SSRs are summarised in Table 3. Comparison
of the SSRs across the four Hi genomes for each of the repeat unit
lengths, reveals that their numbers are not substantially different
between the strains. Also, the total number of repeats foundwithin
any one strain is not substantially different from the others (total
number of SSRs ranged between 53 and 60), despite the differences
in the origin, associated disease and date of isolation of the four
strains (see Table 1).
SSRs have previously been associated with hypermutation, as
loss or gain of repeat units occur at high frequency due to
replication slippage (Moxon et al., 2006). Loss or gain of repeat
units from an SSR located within an ORF may result in a frameshift
mutation if the length of the repeat unit is not a multiple of three.
The position of each of the 223 SSRs identiﬁed in this study was
manually curated and the proportion of SSRs that were located
within ORFs was recorded (see Table 3). Hi has a coding density of
approximately 88% of the genome sequence and, of the repeats
examined, only the trinucleotide (83%), tetranucleotide (100%) and
hexanucleotide (87%) SSRs occur within ORFs at approximately
this frequency, whilst SSRs with repeat unit lengths of one, two,
ﬁve and seven nucleotideswere all found to be locatedwithin ORFs
with a frequency of less than 88%. SSRs with longer repeat unit
lengths were not included in this analysis due to their low
frequency in the genomes.
This suggests that the selective pressure against trinucleotide
and hexanucleotide SSRs occurring within an ORF may not be as
Table 4
Assessment of SSR variability and potential to mediate phase variation in the four
genome study.
Repeat unit
length
Repeat type categoriesa
Potentially phase variable Variable Invariable
1 0 (0) 24 (7) 14 (7)
2 0 (0) 7 (4) 1 (1)
3 0 (0) 12 (9) 6 (6)
4 14 (14) 0 (0) 4 (4)
5 2 (2) 3 (3) 3 (1)
6 0 (0) 8 (6) 2 (2)
7 3 (0) 2 (1) 0 (0)
8 0 (0) 1 (0) 1 (0)
9 0 (0) 3 (2) 2 (0)
Each SSR identiﬁed in the four genome analysis was manually assessed to
determine whether or not it was likely to mediate phase variable gene expression,
from consideration of its position within an ORF or relative to adjacent ORFs,
together with the variation observed between strains. Numbers in bold indicate the
number of each type of SSRwithin each category; numbers in parentheses show the
number of each type of SSR located within predicted ORFs for each category.
a This assessment assigned each SSR to one of three categories: potentially phase
variable – SSRs that both varied in length and were located in positions likely to
inﬂuence gene expression; variable – SSRs that showed differences in length or
sequence between strains but not of a manner consistent with mediating phase
variable expression, and invariable – SSRs that did not show any variation in length,
position or sequence between the strains.
Table 3
The frequency and location of SSRs in the genome sequences of four H. inﬂuenzae
strains.
Repeat
unit lengtha
Threshold
valueb
Genomec
86-028NP Rd KW20 R2846 R2866
1 9 16 (7) 18 (7) 13 (5) 17 (8)
2 5 6 (4) 5 (3) 4 (4) 5 (3)
3 4 8 (6) 13 (11) 11 (10) 9 (7)
4 4 14 (14) 12 (12) 13 (13) 12 (12)
5 3 3 (2) 5 (4) 3 (3) 3 (3)
6 3 4 (3) 5 (4) 3 (3) 3 (3)
7 3 3 (0) 0 (0) 4 (1) 2 (0)
8 3 1 (0) 0 (0) 1 (0) 1 (0)
9 3 1 (0) 2 (0) 1 (1) 2 (1)
Total 56 (36) 60 (40) 53 (39) 54 (37)
The frequency of SSRs, of each repeat motif length, is given for each of the four
genomes in the four genome analysis.
a Repeat unit length: the number of nucleotides that compose a single repeat
unit.
b Threshold value is the minimum number of repeat units required to be present
in an uninterrupted tandem arrangement in order for that sequence to be deﬁned as
an SSR.
c Numbers in bold indicate the number of each type of SSR within each genome;
numbers in parentheses show the number of each type of SSR located within
predicted ORFs for each genome.
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expansion or contraction would result in inactivation of an ORF by
frameshift mutation. It is noteworthy that tetranucleotide SSRs are
found exclusively within ORFs, consistent with the known
importance of this class of repeat in mediating phase variable
expression at contingency loci in Hi.
3.2. Identiﬁcation of repeat unit lengths likely to be associated with
phase variable gene expression
Manual curation of each of the 223 SSRs allowed us to assess the
likelihood of each SSR playing a role inmodulating gene expression.
Comparisonof equivalent SSR loci (those located in the samerelative
genomic location) allowed the classiﬁcation of each SSR into one of
three categories: (1) SSRs that did not vary in length, sequence or
position between the four genomes (invariable), (2) SSRs for which
some variation between strains was observed but the variation was
not considered likely to result in variation of gene expression
(variable) and (3) SSRs that both varied in length andwere located in
regions consistent with mediating phase variation (potentially
phase variable; see Table 4). Careful manual examination of each of
the repeat associated loci was necessary to classify the SSRs into the
above categories. Factors such as the location of the SSR within a
gene, length of the SSR and replacement of awhole or partial tract of
an SSR by another sequence contributed to the assessment of
whether or not any observed variation in the SSR was likely to
mediate phase variation. SSRs located outside ORFs were generally
more difﬁcult to assess as to their likely involvement in phase
variable modulation of gene expression. SSRs have previously been
shown to be mediators of phase variation through modulation of
promoter activity and gene transcription (Dawid et al., 1999;Martin
et al., 2005; vanHamet al., 1993), but promoter regionsof individual
genes often cannot be accurately deﬁned. Thus, the inﬂuence of
variation in SSRs located in non-coding regions on expression of
adjacent genes is difﬁcult to predict. The full assessment of the 223
SSRs identiﬁed within the four genomes can be found in
SupplementaryTable1; a summaryof thedata isprovided inTable4.
The manual classiﬁcation of the SSRs into the three categories
indicated that despite the considerable variation seen between
strains for many of the SSRs (especially the mononucleotide SSRs),
the tetranucleotide, pentanucleotide and heptanucleotide repeattractswere the only types of SSR considered to have a potential role
inmediating phase variable gene expression in these four strains of
Hi (Table 4). The potentially phase variable ORFs associated with
each of these types of repeat are detailed below.
3.3. Tetranucleotide SSRs identiﬁed in the Hi four genome study
Aprevious analysis of the Rd KW20 genome sequence identiﬁed
the primacy of tetranucleotide SSR in mediating phase variation in
Hi (Hood et al., 1996b). This study extends that work by comparing
the tetranucleotide SSRs across four Hi genomes. We identiﬁed 18
different tetranucleotide SSR loci that are distributed fairly
uniformly between genomes with each genome containing from
12 to 14 tetranucleotide SSR loci (Table 5). Eight of the
tetranucleotide SSR loci were found in all four of the strains,
two of the loci were found in three of the strains, three of the loci in
two of the strains and ﬁve of the loci were unique to one strain (two
unique loci in each of the strains Rd KW20 and 86-028NP and one
unique locus in R2846).
Two of the tetranucleotide SSR loci thatwe have identiﬁed in the
four genome analysis have not previously been described as
potential mediators of phase variation in Hi. The ﬁrst of these novel
locicontains14tandem50AGTCrepeatsandisuniquetostrainR2846
(starting at nucleotide 1505819; see Table 5). This SSR is found
immediately downstream of the presumptive start codon of an ORF
encoding a 294 aa proteinwith homology to the glycosyltransferase
2 family of proteins (PFAM PF000535). In Hi, phase variable
glycosyltransferases are frequently involved in LPS biosynthesis
(Hood et al., 1996a). In strain 86-028NP the same glycosyltrans-
ferase is replaced with a different gene (NTHi_1053) that has high
homology (e value of 1  10141, BLASTN) to the phosphoethano-
lamine transferase gene, lpt3, of Neisseria meningitidis (Mackinnon
et al., 2002). This is the ﬁrst report of a gene with signiﬁcant
homology to lpt3 in Hi. Both NTHi_1053 and the gene encoding the
putative glycosyltransferase have an atypically low G + C content
(<30%), suggesting that they have been acquired by horizontal
transfer. The ﬁnding that multiple, distinct gene insertions have
occurred in the same region of the bacterial genome in different
strains may indicate that this is a hotspot for recombination.
The second novel tetranucleotide SSR locus contains a
50CCAA tract associated with a putative glycosyltransferase
Table 5
The sequence and number of repeat units that comprise each of the 199 tetranucleotide SSRs identiﬁed in 16 H. inﬂuenzae genomes.
SSR loci
number
Associated
ORF or
genome
locationa
Descriptionb Repeat
Unit Seq.
Strain
RdKW20 R2866 R2846 86-026 22.1.21 22.4.21 3655 PittAA PitlHH PittII R3021 PittEE PittCG 10810 F3031 F3043
1 HI_0258 igtC glycosyltransferase GACA 22 26 20 10 13 12 12 14 12 16 12 8 38 17 8 24
2 HI_0352 lic3A lipopolysaccharide sialyltransferase CAAT 33 20 26 19 19 19 24 36 20 14 31.8d 19 20 38 22 22
3 HI_0550 tic2A lipopolysaccharide glycosyltransferase CAAT 23 5 25 14 14 e 12 25 11 II 22 23 25 20 15 14
4 HI_1537 licA lipopolysaccharide phosphocholine transferase CAAT 17 36 7 15 22 18 15 25 37 27 15 24 51 47 26 16
5 licA2 lipopolysaccharide phosphocholine transferase CAAT 19 31 17
6 HI_0635 hgp hemoglobin and hemoglobin–haptoglobin
binding protein
CCAA 21 28 25 20 28 16 8 4.10d 4 11 e 8 16 33 29 24
7 HI_0661 hgp hemoglobin and hemoglobin–haptoglobin
binding protein
CCAA 20 27 39 12 6.6d 17 23.8d 19 23 9 20 10
8 HI_1565 hgp hemoglobin and hemoglobin–haptoglobin
binding protein
CCAA 19 28 17 8.12d 16 9 30 15 13
9 HI_0712 hgp hemoglobin and hemoglobin–haptoglobin
binding protein
CCAA 37
10 HI_0687 Drug/metabolite exporter TTTA 6 4
11 HI_1058 mod type III restriction/modiﬁcation system
modiﬁcation methylase
AGCC (TGAC)32
c 16 14 20 12 27 22 IS
12 Hi_1386US Putative glycosyltransferase CCAA 16 8 12 13 10 10 10 7 14 10 10 16
13 Within cryptic yadA-like gene and 245 bp upstream
of tolC-like receptor gene
CAAG 25 13 24 14 17 13 11 30 13 15 17 13 14
14 r2846v6.916 pgtl putative glycosyltransferase GACA 16 14 6 13 5
15 r2846v6.1528c Ipt3 region AGTC 14 10 14
16 r2846v6.1683 lex2A CAAG 24 17 14 18 15 15 24 16 21 22 18 26 14 31
17 r2866v6.124c lav AIDA-I/VirG/PerT family of virulence-associated
autotransporters
CAAG 20 30 14 14 17 28
18 12846 V6.202 oqfA O-antigen lipopolysaccharide acetylase CAAG 9 14 8 12 14 11 14 5 11 8 7 14 11 11
19 NTHI1034 lic3B lipopolysaccharide sialyltransferase CAAT 15 21 10 12 24
20 PITTII Gene encoding a YadA domain containing protein CAAG 20 15 24
21 F3043-1499724 Gene encoding a YadA domain containing protein CAAG 19
22 F3043-196894 Gene encoding a YadA domain containing protein CAAA 15 13
23 F3043-756964 225 bp upstream gene encoding a YadA domain
containing protein
CAAA 16 31
24 F3043-609747 Glycosyltranslerase (family 8) with framshift CAAT 18 33
25 F3043-1083776 Gene encoding a YadA domain containing protein CAAG 23
26 F3043-1500170 SAM-dependent methyltransferase CAAT 21
27 F3043-1598734 225 bp upstream formamidopynmidine-DNA
glycosylase (mutM)
ATTA 9
28 F3031-1121634 58 bp upstream adenine speciﬁc methylase (EcoRI)
and 202 bp upstream of htpX (heat shock protein)
CAAG 32
Listed in this table are the 199 tetranucleotide SSRs that are associated with the 28 loci identiﬁed in this analysis of the genomes of 16 Hi strains.
a The associated ORF designation in the Rd KW20 genome, or when not present in the Rd KW20 genome the R2486, R2866 or 86-028NP genomes. SSR from unannotated genomes are identiﬁed by the strain, a hyphen and the
nucleotide number at which they are found.
b Genes associated with the SSR. The gene names and predicted functions are from BLAST similarity searches and the published genome annotations.
c The sequence of the tetranucleotide SSR in this locus is different to that associated with this gene in all other strains (50AGCC).
d x. . .y indicates that there are x number of the tetranucleotide repeat unit, followed by an interruption, followed by y number of tetranucleotide repeat units.
e The presumptive position of the SSR loci is at the end of a contig and its presence or absence cannot be determined.
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genomes examined with between 8 and 16 repeat units and
constitutes the ﬁrst example of a 50CCAA tract that is associated
with a gene other than iron utilisation genes in Hi (Jin et al., 1996;
Morton and Stull, 1999).
3.4. Pentanucleotide SSRs identiﬁed as potential mediators of phase
variation in Hi
A total of eight pentanucleotide SSR loci were identiﬁed across
the fourHi strains investigated, sixof thesewere locatedwithinORFs
(see supplementary Table 1). The lengthof the pentanucleotide SSRs
ranged from three to twelve units but the majority were of the
minimumthresholdvalueof threeunits. Twoof thepentanucleotide
SSRs locatedwithin ORFs are of particular interest. The ﬁrst of these
pentanucleotide SSRs is associated with the type I modiﬁcation
enzyme, HsdM (the ORF in the Rd KW20 genome (HI1287) is
truncated due to the repeat), and has previously been implicated in
the phase variable expression of this type I restriction-modiﬁcation
gene (Zaleski et al., 2005). The SSRs identiﬁed in the four genome
study are one, two or four units in length. van Belkum et al. (1997)
and van Belkum (1999) described length variation in the region of
this pentanucleotide repeat in a survey of 20Hi strains. Zaleski et al.
(2005) estimated the phase variation rates of the (50GACGA)4 (4
tandem repeats of the sequence 50GACGA30) pentanucleotide repeat
at this locus from observations on the degree of bacterial lysis
induced by exposure to phage HP1c1. The rates they recorded for a
change from four to three pentanucleotide repeats in strain RM118
were high and equivalent to those previously measured for much
longer tetranucleotide repeat tracts (De Bolle et al., 2000) in the
same strain.
The second coding pentanucleotide SSR of interest (50TCAGC)
was found in a gene of the hmg locus that encodes a highmolecular
weight glycoformof the LPS (Hood et al., 2004). The two repeat unit
pentanucleotide SSRs present in Rd KW20 and R2846 (within the
ORFs HI0867 and Hﬂu103000281, respectively) are consistent with
the expression of a putative LPS ﬂippase, whilst the three unit SSR
in R2866 is inconsistent with expression of this gene. It is
noteworthy that these two potential phase variation-mediating
pentanucleotide SSRs relate to gene functions (restriction-mod-
iﬁcation and LPS modiﬁcation) whose expression has previously
been reported to be phase varied by tetranucleotide SSRs.
3.5. Heptanucleotide SSRs as mediators of phase variation in Hi
Four heptanucleotide SSRs were found in the survey of the four
Hi genomes, three of which we have designated as potential
mediators of phase variation. Two of these heptanucleotide SSRs
are located approximately 100 bp upstream of the hmw1a and
hmw2a genes and have previously been described by Dawid et al.
(1999). They reported that these SSRs are within the promoters of
the hmw1a and hmw2a genes and that alteration of the number of
repeat units present in these SSRs results in a modulation of gene
expression. The exact mechanism by which these SSRs inﬂuence
transcription from these genes remains to be determined but may
involvemodulation of transcription from two alternative start sites
(Dawid et al., 1999). Strain R2846 has (50TGAAAGA)17 and
(50TGAAAGA)16 for hmw1a and hmw2a, respectively, and strain
86-028NP has (50TGAAAGA)17 and (50TGAAAGA)23 units for
hmw1a and hmw2a, respectively, but there are no equivalent loci
or repeat tracts in the other two genomes.
The third heptanucleotide SSR with a potential to mediate
phase variation is the (50AACAACC)1-7 tract situated only 13 bp
upstream of a gene encoding a member of the TonB-dependent
receptor family (PF0593) that has similarity to Fe transport
proteins. One unit of the repeat is found in the genomes of strainsRd KW20 and R2846, seven in R2866 and six in 86-028NP. Rd
KW20 and R2866 appear to have full lengthORFs but the 86-028NP
ORF is disrupted by a frameshift unrelated to the SSR. The observed
variation in the length of this SSR, together with its position so
close to the start of the downstream ORF, led us to postulate that it
may mediate phase variation in Hi.
3.6. Other types of SSRs identiﬁed in the Hi four genomes study are not
considered to mediate phase variable gene expression
Analysis of mononucleotide, dinucleotide, trinucleotide and
hexanucleotide SSRs in the four genome study did not provide any
evidence to suggest to us that these classes of repeat were
associated with phase variable gene expression as detailed below.
3.7. Mononucleotide SSRs in the four Hi genome are predominantly
short A or T tracts
Mononucleotide SSRs have previously been documented as
important mediators of phase variation in species such as Neisseria
meningitidis (Schoen et al., 2007), Bordetella pertussis (Gogol et al.,
2007) and Campylobacter jejuni (Hofreuter et al., 2006; Pearson
et al., 2007). Perhaps surprisingly, they have not been implicated in
phase variation in Hi, although partial sequencing of the iga gene
from some Hi biogroup aegyptius strains led the investigators to
suggest that a G10 tract found in only one strain may have
mediated phase variable expression of the gene (Kilian et al., 2002).
Our analysisof themononucleotide SSR loci present in the fourHi
genomes revealed a considerable degree of heterogeneity in this
class of SSR between these strains. 64 homopolymeric tracts were
identiﬁed across the four genomes and Supplementary Table 1
summarises their characteristics. 28/64 (44%) of the mononucleo-
tide SSRs were found within ORFs and although variations were
frequently observed between strains they were not consistent with
mediatingphasevariation (seeSupplementaryTable1). Theﬁndings
from the genome of strain Rd KW20 were representative of the
distributionofmononucleotide SSRs found in the threeother strains.
All of the mononucleotide SSRs in this strain were A or T tracts (18/
18) and most were the minimum threshold length of 9 units in
length (16/18). Comparison across the four strains revealed that the
variation observed in the equivalent mononucleotide SSRs of 8–10
units usually occurred by the substitution of one of the baseswithin
the homopolymeric tractwith a different base (e.g. an (A)9 tractwas
foundas (A)7CA in somestrains). All substitutions interrupting theA
or T homopolymeric SSRs were found to be G or C nucleotides,
suggesting an uneven pattern of mutation.
Examination of the further three genomes identiﬁed some
anomalous mononucleotide SSRs. The ﬁrst is an exceptionally long
(A)34 tract identiﬁed in strain R2866. This SSR was located 120 bp
upstream of the start of the ORF encoding the autotransporter
adhesin Hia, which is an autotransporter protein containing the
YadA domain and is believed to bind vitronectin and aid survival in
human serum (Cotter et al., 2005a; Hallstro¨m et al., 2006; Meng
et al., 2006). This SSR is not obviously associated with a promoter
region and its function, if any, remains unclear. The second and
third are a (G)12 and a (C)11 repeat tract both found in the genome
of strain 86-028NP, and which are noteworthy because mono-
nucleotide SSRs of G or C residues are uncommon in Hi, reﬂecting
the low G + C content of this organism (38%). The (G)12 SSR was
within the 50 end of ORF ntHI0694. This gene shows homologywith
genes encoding methyltransferases of the FkbM family, some of
which are involved in the biosynthesis of methylated sugars in
Rhizobium etli LPS (Duelli et al., 2001). This gene has not been
identiﬁed in other Hi strains and suggests that 86-028NP LPS may
be O-methylated. The (C)11 SSR was located 230 bp upstream of
the acpP gene (ntHI0243). Members of the AcpP family are short
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considered house keeping proteins. In the three other genomes the
tract at the same location contains ﬁve C residues.
3.8. Dinucleotide SSRs in the Hi four genome study
Phase variation mediated by dinucleotide repeats has been
documented previously in Hi. A (TA)9-11 tract, located in the
promoter region of two divergently transcribed genes, hifA and hifB
was shown to control ﬁmbriae biogenesis in some strains (van Ham
etal., 1993). Thehif locus ispresent inonly20%ofNTHi strainsand,of
the four strains analysed here, only R2866 contains the hifA and hifB
genes. In this strain, however, the 50TA tract was present as a
50(TA)4ATTAsequence. The threshold value set fordinucleotideSSRs
in this study was ﬁve, therefore this tract was not identiﬁed as an
SSR; further discussion of this locus is found later in this paper.
Eight dinucleotide SSR loci were identiﬁed in this four genome
analysis, all of which were found to be of the threshold value of ﬁve
repeat units in length. Five were located within coding regions. In
a similar fashion to the variation observed for many of the
mononucleotide SSRs, seven of the dinucleotide SSR loci were
found to have sequence variations that did not alter the overall
length of the sequence between strains and so would not cause
frameshifts consistent with phase variation. For example, a (CA)5
repeat conserved in the genomesof strains RdKW20, R2846 and86-
028NP was found to be replaced with CACG(CA)3 in strain R2866.
3.9. Trinucleotide SSRs were predominantly found to be located
within ORFs
Eighteen trinucleotide SSRs were identiﬁed in this study, the
majority of which, (15/18), were located within coding regions. All
of these 15 SSRs consisted of no more than four repeat units and
where variation in the repeats was observed between strains, it
either resulted in a reduction in length of the SSR or disruption of
the sequence whilst maintaining the same length. The three
trinucleotide SSRs that were found in non-coding regions showed
greater variation in overall length but were not within identiﬁed
promoter or other regulatory regions.
3.10. Hexanucleotide SSRs identiﬁed in the four genome study
Ten hexanucleotide SSRs were identiﬁed within the four
genomes, eight within ORFs and two in non-coding regions.
Variation in coding hexanucleotide repeats can lead to altered
amino acid sequence but not phase variable gene expression. The
coding region hexanucleotide SSRs identiﬁed in this study were
either conserved or, like the mononucleotide and dinucleotide
variations discussed above, showed changes in sequence but not
length and thus were inconsistent with modulating phase variable
expression.Of the twonon-coding regionassociatedhexanucleotide
repeats, one is conserved across all four strains and is present
downstream of the closest ORFs, whilst the other 50TTAAAA SSR is
present as three repeatunits inRdKW20, twounits in86-028NPand
as two units plus an interrupted third repeat unit in R2866 and
R2846. This SSR is situated 19 bp from the start codon of HI0525 in
strain RdKW20,which encodes a phosphoglycerate kinase involved
incentralmetabolismandthe inﬂuenceof this SSRon theexpression
of this ORF is unknown.
3.11. SSRs with repeat units greater than 7 nucleotides are not found
at high frequency in the four genomes
Of the limited number of SSRs with repeat unit lengths greater
than seven nucleotides that were identiﬁed in the four genomes
study, most were found in only one strain. These include a non-anucleotide SSR found in the genome of strain 86-028NP. This
(50GTTTTCTTA)19 SSR was found to be located 92 bp upstream of
the hmw2C gene. As discussed above, variations in heptanucleotide
SSR associated with the hmw2A loci are thought to modulate gene
expressionbut the functionof thisnonanucleotideSSR isnot known.
An octanucleotide (50ATTATTTG) SSR however, was found in
multiple strains, varying in length between 1 and 6 repeat units.
Itwas found tobe locatedbetween the divergently transcribed cmkB
and pdxS genes which encode a cytidylate kinase 2 and a pyridoxal
biosynthesis lyase, respectively, (designated HI1646 and HI1647 in
strain Rd KW20). They are both suggested to play roles in
metabolism and so it is uncertain whether this SSR would actually
be utilised in modulating their expression.
3.12. Analysis of the SSRs of a further 12 genomes
Whilst the SSR analysis of the four Hi genomes was ongoing, 12
furtherHi genomeswere sequenced and the resulting full or partial
sequences made publicly available (listed in Table 1). These 12
additional genome sequences offered us the chance to conﬁrm and
extend our detailed SSR analysis of the four Hi genomes.
Using the same SSR search methods and threshold values
described for the four genome study, 765 SSRs were identiﬁed in
these 12 additional genomes (summarised in Table 6). From these
data itwas seen thatmononucleotide SSRs are found in 10 out of 12
of the additional genomes at a higher frequency thanwas observed
in the four genome study. However, it should be noted that the 454
sequencing technology used to generate themajority of the further
genome sequences has a decreased ﬁdelity for mononucleotide
tracts whichmay account, to some extent, for the higher number of
mononucleotides SSR detected in these strains. However, the
F3031 and F3043 genomes, for which the highest number of
mononucleotide SSRs were identiﬁed, were sequenced using ABI
Sanger dideoxy sequencing technology.
In a high proportion of the additional genomes, tetranucleotide
and hexanucleotide SSR were also observed more frequently than
in the four genome study.
3.13. Tetranucleotide SSRs in the complete genome collection
The nine NTHi genomes, sequenced by the Center for Genomic
Sciences (Hogg et al., 2007) (see Table 1), and the genome of strain
10810, contained a similar number of tetranucleotide SSRs to that
previously observed in the four genome study (12-14 per genome)
and only two novel tetranucleotide SSR loci were identiﬁed.
Conversely, in the genomes of strains F3031 and F3043, 18 and 21
tetranucleotide SSR loci were identiﬁed, respectively, and eight of
these tetranucleotide SSRs were not identiﬁed in any of the
previously analysed genomes (see Table 5).
3.14. Ten novel tetranucleotide SSRs
A total of tennovel tetranucleotide SSR lociwere identiﬁed in the
additional twelve genomes. One locus, licA2 is a duplication of the
licA locus reported in the four genome study (Fox et al., 2008) Five of
the novel tetranucleotide SSR were associated with genes encoding
members of the trimeric autotransporter protein family which
commonly contain a C-terminal YadA domain (PFAM03895) (Cotter
et al., 2005b; Koretke et al., 2006). All ﬁve of these paralogous loci
were present in the two Hi biogroup aegyptius strains F3031 and
F3043 and one of the lociwas alsopresent in the genomeof theNTHi
strain, PittHH. Previously described members of this family of
proteins from Hi include the adhesins Hsf and Hia which have been
implicated in virulence (Cotter et al., 2005a; Surana et al., 2004). It
can be envisaged that the expression of adhesins may not be
advantageous in all growth conditions as they are possible targets
Table 6
The number of SSRs, of each repeat unit length, in each genome.
Repeat unit
length
Range in four
genome studya
Strainsb
22.1.21 22.4.21 3655 PittAA PittHH PittII R3021 PittEE PittGG 10810 F3031 F3043
Mono 13–17 25 21 22 20 20 20 28 12 19 16 30 25
Di 4–6 6 8 2 3 6 6 5 2 6 4 7 5
Tri 8–13 12 13 11 11 6 10 12 13 14 12 10 6
Tetra 12–14 11 9 17 13 9 15 8 14 13 10 18 21
Penta 3–5 4 2 3 4 3 4 2 3 6 2 6 5
Hexa 3–5 6 4 2 6 6 5 4 7 5 8 9 5
Hepta 0–4 2 1 2 4 1 2 2 4 1 0 3 1
Octa 0–1 1 1 2 1 2 1 0 0 0 1 5 5
Nona 1–2 0 0 2 1 0 0 0 0 3 0 0 0
Total 53–60 67 59 63 63 53 63 61 55 67 53 88 73
Analysis of the number of SSRs identiﬁed in the 12 genome study compared to the four genome study. Numbers given in bold or italic indicate that the value is higher or lower
than the four-genome study range, respectively.
a The minimum and maximum number of each type of SSR observed per genome in the four genome study.
b The number of SSRs per genome, of each repeat unit length, in the 12 genome study.
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whose expressionwould require considerable resources. Indeed, the
NadAprotein fromN.meningitidiswhich isamemberof this familyof
proteins, has previously been shown to be phase variably expressed
(Capecchi et al., 2005; Martin et al., 2005). Hi biogroup aegyptius
strains have been associatedwith atypical invasive disease and it is,
therefore, tempting to speculate that the high number of putative
phase variable adhesins identiﬁed in strains F3031 and F3043 may
somehow contribute to the unusual clinical outcomes associated
with these strains.
An additional four novel tetranucleotide SSRs were identiﬁed
from strains F3031 and/or F3043. The ﬁrst, a (50ATTA)9 SSR is found
225 bp upstreamof a gene encoding a putative DNA repair enzyme,
formamidopyrimidine-DNA glycosylase MutM, in strain F3043.
The equivalent position in other Hi strains contains 3 copies of the
50ATTA repeat unit. The role of this repeat in expression of MutM is
unknown but variations in the expression of mutM could
potentially result in alteredmutation rates inHi (Horst et al., 1999).
The second novel tetranucleotide SSR identiﬁed from strains
F3031andF3043 is a 50CAATSSR containedwithin the50 regionof an
ORF that encodes a putative glycosyltransferase with homologies to
glycosyltransferase family 8 (PFAM01501). Homologues of this gene
are found in other strains ofHi (includingHI0223 in strain RdKW20)
butwithout the associated SSR. The functionof this gene isunknown
but it may contribute to LPS expression in strains F3031 and F3043.
The third of the four additional novel tetranucleotide SSR loci
contains (50CAAT)21 andwas foundonly in strain F3043. It is located
within the 50 end of an ORF that encodes a putative S-adeno-
sylmethionine (SAM)-dependent methyltransferase and shows
some homology to HI0096 in strain Rd KW20. SAM-dependent
methyltransferases have been implicated in various cellular
processes including protein trafﬁcking and sorting, signal transduc-
tion, biosynthesis, metabolism, and gene expression.
The ﬁnal novel tetranucleotide SSR identiﬁed in strain F3031 is
a (50CAAG)32 SSR located 58 bp upstream of a gene encoding
an adenine speciﬁc methylase homologue (EcoRI) and 202 bp
upstream of the divergently transcribed htpX (which encodes a
putative protease protein, induced by heat shock in E. coli). HtpX
has not been investigated in Hi but in E. coli it is part of the
membrane-localised proteolytic system and may play a part in the
degradation of unstable membrane proteins (Sakoh et al., 2005).
3.15. Consideration of characteristics of tetranucleotide repeats from
the complete genome collection
In total, 199 tetranucleotide SSRs associated with 28 different
loci and consisting of nine different repeat unit sequences havebeen identiﬁed in the complete genome collection. The distribu-
tion of tetranucleotide SSR length, and the relationship between
length of tetranucleotide SSR and strain are shown in Fig. 1. The
length of an individual tetranucleotide SSR does not appear to be
dependent on strain background, repeat unit sequence or locus
(Fig. 1B), and a wide degree of variation and considerable overlap
between groupings is observed. Fig. 1A shows that despite
differences in the source, date of isolation and associated clinical
symptoms of the different strains there is an approximately normal
distribution of tetranucleotide SSR lengths. Fig. 1B shows that the
two Hi biogroup aegyptius strains F3031 and F3043, which are
associated with unusual clinical symptoms and have the highest
number of tetranucleotide SSR, display a similar distribution of SSR
lengths to all other strains.
3.16. Consequences of the sequence and location of tetranucleotide
SSR
As noted previously, the tetranucleotide SSRs identiﬁed in the
four genome study ofHi are located within ORFs and, with only two
exceptions, are located immediately adjacent to or just downstream
of the translational start site. In this position, any frameshift due to
variation in length of the SSR, would result in a peptide being
made from the incorrect reading frame and a premature stop to
translation. The location of tetranucleotide SSRswithin the 50 region
of theORFs limits the encodedtetrapeptide repeat to theN-terminus
of the respective protein. The two exceptions to this pattern are the
50GCAA tetranucleotide SSR located in the middle of the oafA gene
that has been previously described (Fox et al., 2005), and a 50GACA
tetranucleotide SSR located in the 30 region of a gene encoding a
putative glycosyltransferase (pgt1) in the genomes of strains R2846,
86-028NP, 3655andPittEE. These repeatsmaymodulate theprotein
function rather than control ON/OFF switching of its expression.
Tetranucleotide SSRsmay constitute a substantial proportion of
the coding region of a gene and thus the repeat unit sequence will
have a signiﬁcant inﬂuence on the amino acid composition of
the encoded protein. The constraints that this may impose, in
terms of permissible tetranucleotide sequences, have not been
well characterised although High et al. (1996) suggest that the
peptides encoded by the repeat regions form structurally ﬂexible
regions that loop out of the protein structure and therefore do not
interfere with tertiary structure.
An in silico analysis of the repeat sequences identiﬁed in the 16
Hi genomes analysed was performed and hydrophilic amino acids
are over represented in the SSR encoded peptides, compared with
their frequency in the normal proteome. Of the eight tetranu-
cleotide repeat sequences found within ORFs in Hi, ﬁve encode
Fig. 1. Histogram and boxplot representations of the length distribution, sequence, strain and loci associations of tetranucleotide SSRs. (A) Frequency histogram of
tetranucleotide SSR length distribution in the complete genome study. (B) Boxplot analysis of the relationship between the strain fromwhich the genomewas derived and the
length of the tetranucleotide SSRs.
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50AGCC, and 50AGTC), one encodes a hydrophobic peptide with no
net charge (50TTTA) and two encode hydrophilic peptides with a
net positive charge (50GCAA and 50CAAA). The high proportion of
hydrophilic peptides encoded by the tetranucleotide SSRs and their
frequent N-terminal location suggests that they are likely to be
surface exposed and have the opportunity to ‘loop out’ of the
folded protein structure and thus be less likely to interferewith the
tertiary structure of the protein and, therefore, its function. The
exception is a 50TTTA tetranucleotide SSR which encodes a
hydrophobic peptide within a putative drug/metabolite exporter
(HI0687 in strain Rd KW20). Transmembrane helices predictions
(TMHMM server v2.0, Sonnhammer et al., 1998) suggest that the
portion of this protein encoded by the SSR lies entirely within a
transmembrane domain. Examination of homologues of the
HI0687 gene indicates that the hydrophobic nature of such
transmembrane helices is well conserved but often the primary
sequence is not (data not shown). Another observation of this
study was that although previously SSRs of a particular tetra-
nucleotide repeat unit sequence have been associated with genes
of related function, e.g. 50CCAA tracts with genes encoding iron
utilisation proteins (Jin et al., 1996;Morton and Stull, 1999), in this
study, we have found no evidence of a particular tetranucleotide
repeat unit sequence being restricted to a particular class of gene.
3.17. Interrupted tetranucleotide SSR may be an indication of intra-
genome recombination between paralogous loci
One feature of certain tetranucleotide SSR, noted during the
course of this study was their interruption by an imperfect repeat
unit. All of the genomes in this study were found to contain
between one and four related, hemoglobin/hemoglobin–hapto-globin-binding (hgp) genes containing 50CCAA SSR that show
considerable variation in length. Hi lacks most of the genes of the
heme biosynthetic pathway and requires hemoglobin/hemoglo-
bin–haptoglobin-binding proteins to capture heme-containing
compounds required for growth (Morton and Stull, 1999). Seven
interrupted tetranucleotide SSRs were observed in total in this
analysis of which six were found to be associated with hgp genes.
We postulate that homologous recombination occurring between
these paralogous loci may occasionally generate imperfect repeats
and it will be of interest to ascertain whether similar events occur
between other duplicated loci, e.g. paralogous adhesin genes
(discussed below), partial or fully duplicated hifA loci and
duplicated lic1A genes (strain PittGG).
3.18. Mononucleotides identiﬁed as potential mediators of phase
variation in the analysis of the 12 further genomes
In contrast to the four genome study, the analysis of the 12
additional Hi genomes has identiﬁed a number of mononucleotide
SSRs with the potential to mediate phase variable gene expression.
These mononucleotide SSRs were located within the 50 coding
regions of ORFs, associated with frameshift mutations, or located
within potential promoter regions. The potential phase variable
genes include those encoding virulence-related factors such as
glycosyltransferases, type-I restriction modiﬁcation systems,
haemagglutinins, YadA domain containing proteins, pilin genes
and a Fe–S cluster assembly scaffold protein (see Table 7). This
study offers the ﬁrst indication that mononucleotide SSRs may
mediate phase variation in Hi.
Further support to the role of the mononucleotide SSRs in
mediating phase variation in Hi is that some genes identiﬁed in the
12 genome study have previously been determined to be phase
Table 7
Notable non-tetranucleotide SSRs identiﬁed in complete H. inﬂuenzae genome collection.
Genome Repeat unit
length
Repeat unit
sequence
Number of
repeatsa
Description of locationc Genome
location (bp)b
F3043 1 A 17 67 bp upstream of hifA (pilin) 1039014
F3043 1 A 12 93 bp upstream of hifA (pilin) 1207519
F3031 1 G 13 10 bp within putative YadA-domain containing protein encoding gene 548152
F3031 1 G 9 FS 625 bp into putative glycosyltransferase gene 556417
F3031 1 G 9 FS 641 bp into type I restriction-modiﬁcation system gene 751900
F3031 1 T 12 3 bp upstream of putative YadA-domain containing protein encoding gene 1367593
F3031 1 T 12 93 bp upstream of hifA (pilin) 1705139
PittEE 1 C 12 FS within 30 end of a putative O-methyltransferase encoding gene (31% GC) 10582
PittEE 1 C 9 115 bp within Fe–S cluster assembly scaffold gene 697640
PittEE 1 G 9 324 bp within transferrin-binding protein 2 gene 1384490
r3655 1 G 15 118 bp upstream of exonuclease ABC subunit C 1266118
r3655 1 T 12 upstream hemoglobin-binding protein A encoding protein encoding gene 1338394
r3655 1 G 10 FS 114 bp within Fe–S cluster assembly scaffold protein encoding gene 1547902
PittAA 1 C 9 114 bp within Fe–S cluster assembly scaffold protein encoding gene 1350019
PittAA 1 C 11 454 bp within O-methyltransferase gene 1764602
PittII 1 C 9 within truncated lic3B, not in other strains 237746
PittII 1 T 36 120 bp upstream of YadA-domain containing autotransporter adhesin gene 983892
R3021 1 T 49 122 bp upstream of YadA-domain containing autotransporter adhesin gene 701090
22.1.21 1 T 20 121 bp upstream of YadA-domain containing autotransporter adhesin gene 1278422
10810 1 A 38 120 bp upstream of YadA-domain containing autotransporter adhesin gene 1960236
F3031 2 TA 10 225 bp upstream of hifA, 121 bp upstream of hifB (chaperon) 45074
F3031 2 TA 10 225 bp upstream of hifA, 121 bp upstream of hifB (chaperon) 150062
F3031 2 TA 8 104 bp upstream of YadA-domain containing protein gene 1258000
22.1.21 2 TA 9 166 bp upstream of hifA (pilin), truncated hifB (chaperon) 52984
22.4.21 2 TA 9 133 bp upstream of hifA (pilin), truncated hifB (chaperon) 937926
PittEE 7 TGAAAGA 13 69 bp upstream of hmw1A 750553
PittEE 7 TGAAAGA 38 104 bp upstream of hmw2A, 154 upstream of NTHI1451 homolog 1118607
PittAA 7 AATTTTG 14 FS 3.5 kb within hmw1A 1861090
PittAA 7 TGAAAGA 16 106 bp upstream of hmw1A 876652
r3655 7 AACAACC 8 FS within HI1369 (Fe ligand_gated_channel, TonB dependent) 763559
22.4.21 7 AACAACC 13 77 within HI1369 (Fe ligand_gated_channel, TonB dependent) 1296925
F3043 8 ATTATTTG 6 12 bp upstream of pyridoxine biosynthesis protein gene 1003128
F3043 8 GCATCATC 13 213 bp upstream of hmw1A 1315267
F3043 8 GCATCATC 12 209 bp upstream of hmw2A 192933
F3031 8 GCATCATC 15 200 bp upstream of hmw2A 1349049
F3031 8 GCATCATC 14 213 bp upstream of hmw1A 1603867
r3655 8 ATTATTTG 6 12 bp upstream of pyridoxine biosynthesis protein (near end of contig) 1203993
PittHH 8 ATTATTTG 4 12 bp upstream of pyridoxine biosynthesis protein gene 1799917
PittAA 8 ATTATTTG 4 12 bp upstream of pyridoxine biosynthesis protein gene 430306
PittII 8 ATTATTTG 6 12 bp upstream of pyridoxine biosynthesis protein gene, 77 bp upstream
of cytidylate kinase gene
1077736
22.1.21 8 ATTATTTG 4 12 bp upstream of pyridoxine biosynthesis protein gene, 77 bp upstream
of cytidylate kinase gene
1370808
10810 8 ATTATTTG 6 12 bp upstream of pyridoxine biosynthesis protein gene, 77 bp upstream
of cytidylate kinase gene
1862249
PittGG 9 CTTGTTTTT 6 8 bp within/13 bp upstream of low similarity to O-antigen polymerases
encoding gene
1453483
Analysis of the twelve additional Hi genomes identiﬁed 43 non-tetranucleotide SSRs that could potentially mediate phase variation.
a The number of tandem repeat units that comprise the SSR.
b The base pair at which the 50 base of the SSR is located.
c Location of the SSR relative to, and description of the function of, the ORF whose expression it is proposed to modulate. FS: ORF associated with SSR has a frameshift
mutation, bp: base pair.
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divergently transcribed pilin genes, hifA and hifB,which Geluk et al.
(1998) demonstrated to be phase variable due to variation in
the length of a 50TA SSR located between them and 104–225 bp
upstream of the hifA gene. Changes in the length of the
dinucleotide SSR were proposed to alter the spacing between
the 10 and 35 promoter sequences and therefore alter expres-
sion of the genes. In strain F3031, there are four hifA loci in total.
Two of the loci have an arrangement similar to that described by
Geluk et al. (1998) with the 50TA SSR located between the
divergently transcribed hifA and hifB genes whilst the other two
hifA loci havemononucleotide (A17 or A12) instead of dinucleotide
SSRs located either 63 or 93 bp upstreamof hifA (see Table 7). There
is no hifB gene associated with these latter loci. Phase variation of
pilin expression mediated by mononucleotide SSRs has not been
previously reported in Hi. The exact location and extent of the
promoter region of hifA has not been mapped in these strains, butthe position of the mononucleotide SSRs makes them a candidate
to mediate phase variation.
In the four genome study, homopolymeric A or T tracts of less
than 11 bpwere foundwith only one exception, an A34 tract found
in the R2866 genome. In the additional twelve genomes a similar
tract of between 20 and 49 bpwas found in four strains in the same
genomic location; approximately 120 bp upstream of the nearest
ORF which encodes a protein with homology to YadA-domain
containing proteins such as Hsf. The function of this SSR is
unknown but it is tempting to speculate that it may play a role in
regulating the expression of the downstream Hsf-like encoded
protein. Similarly, in the genome of strain F3031 the expression of
a number of YadA domain containing proteins was suggested to be
mediated by tetranucleotide SSRs (see Table 5). However in one
instance, the expression of a YadA domain containing protein in
this strain is potentially mediated by a G13 SSR (located at
base 548152) located 10 bp within the ORF (see Table 7). The
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paralogs of genes which are phase variable by other SSRs offers
strong circumstantial evidence that these mononucleotide SSRs
may mediate phase variation in Hi.
3.19. Other potentially phase variable SSRs in the complete genome
collection
TheheptanucleotideSSRsassociatedwith thehmw1aandhmw2a
genes in the four genome studywere also identiﬁed in the genomes
of strains PittEE andR3655 in the 12 furtherHi genomesanalysed. In
PittEE, 13 copies of the heptanucleotide repeat are present 69 bp
upstream and 38 copies 104 bp upstream of the hmw1a and hmw2a
genes, respectively, and inR3655, 16 copies of the repeat arepresent
106 bp upstream of hmw1a. However, in the further genome study,
anadditionalnovelheptanucleotideSSRassociatedwithhmw1awas
identiﬁed in the genome of strain PittAA. Interestingly, this SSR,
consisting of (50AATTTTG)14, was 3.5 kb within the 7.3 kb putative
full length ORF rather than in the promoter region, and a frame shift
hadoccurredwhich is consistentwith this being caused byvariation
in the length of the SSR. In the further genome analysis, an
octanucleotide SSR was found associated with hmw loci. This SSR
contained twelve to ﬁfteen copies of a 50GCATCATC repeat and was
identiﬁed 200–213 nucleotides upstream of the hmw1a and hmw2a
loci of strain F3043 and F3031.
A further novel heptanucleotide SSR with the potential to
mediate phase variation was identiﬁed in strains 22.4.21 and
R3655, within an ORF which is a homologue of the HI1369 gene
(encoding a putative TonB dependent iron ligand gated channel).
Thirteen units of the 50AACAACC repeat are found in 22.4.21, and
eight repeat units in strain R3655 which results in a truncated ORF
due to a frameshift.
An octanucleotide SSR identiﬁed in the four genome study as
containing one, four or six copies of a 50ATTATTTG unit 12 bp
upstream of a gene encoding a pyridoxine biosynthesis protein,
was also identiﬁed in seven strains of the further twelve genome
collection (four copies of the SSR in strains PittHH, PittAA and
22.1.21 and six copies in strains R3655, PittII, F3043 and Hib; see
Table 7). However, the limited range of variation and relatively
short length of this SSR are not what would be expected at a
classically phase variable locus and so the signiﬁcance of this SSR at
this location remains uncertain.
4. Discussion
The complete genome sequence of Hi, strain Rd KW20
(Fleischmann et al., 1995), provided for the ﬁrst time the means
to analyse the gene content, organisation and sequence structure
of a free-living organism. One of the major ﬁndings in Hi strain Rd
KW20 was the association of SSRs, especially tetranucleotide SSRs,
with genes involved in host adaptation, commensalism and
virulence (Hood et al., 1996b). SSRs are hypermutable andmediate
a high frequency of reversible increases or decreases in the number
of repeat units resulting in phase variable expression of the
associated genes (Moxon et al., 2006).
As sequencing techniques have progressed, the easewithwhich
sequencing data can be gathered has increased. As a result, the
sequences of multiple strains of a single species have become
available for comparison and the extent of genomic variation
between strains has become evident. In this study, our aim was to
extend our understanding of the role of SSRs in the biology and
pathogenicity of Hi by an analysis of four complete genome
sequences and a survey of available sequence data for a further
twelve strains.
SSRs, consisting of repeat units of between one and nine
nucleotides in length, were characterised. For this analysis to bepractical, it was necessary to establish threshold values, above
which tandem repeat units were designated as SSRs. Data
pertaining to the genomic location, position relative to the nearest
ORF and the types of polymorphism observed by comparison
between genomes was compiled for each of 223 SSRs in the initial
survey of the four complete Hi genome sequences from strains Rd
KW20, R2846, R2866 and 86-028NP. These SSRs were broadly
classiﬁed into three categories; invariant, variant and potentially
phase variable. Invariant SSRs showed no variation in sequence,
position or length between strains whilst variant SSRs showed
some variation between strains but not of a type that would
mediate phase variation, i.e. they usually showed some variation in
sequence but not overall length. Potentially phase variable SSRs
showed variation in the number of repeat units constituting the
SSR between strains and were in positions consistent with
mediating phase variation either within ORFs or promoter regions.
The majority of SSRs examined fell into the ﬁrst two classes. From
the further 12 partial and complete genome sequences, 765
additional SSRs were identiﬁed.
These studies have conﬁrmed that tetranucleotides are the
predominant class of SSR to mediate phenotypic variation via
phase variation in Hi. A total of 199 tetranucleotide SSRs were
found distributed across the 16 strains, associated with 28
different loci (see Table 5). Of these, 10 were novel tetranucleo-
tides, eight of which were identiﬁed in the genome sequences of
only two strains, the Hi biogroup aegyptius strains F3031 and
F3043. Tetranucleotide SSRs were found associated with a number
of paralogous adhesin genes in these strains and, intriguingly, with
a mutM locus that could potentially modulate mutation rates due
to oxidative damage (Horst et al., 1999).
The Hi biogroup aegyptius strains, F3043 and F3031 isolated in
Brazil, were associated with conjunctivitis and BPF, respectively. A
relevant question is whether the increased number of tetranucleo-
tide SSRs in these strainsmay contribute to their unusual virulence
phenotype. A detailed analysis of the characteristics of the
tetranucleotide SSRs across all strains showed that whilst the
number of tetranucleotide SSRs was higher in the biogroup
aegyptius strains (Table 6), the length or sequence of the SSRs was
similar between all the strains (Fig. 1 and unpublished data).
Indeed, no relationship was found between the sequence, length,
genomic locus or protein function of tetranucleotide SSRs. Other
tetranucleotide SSR loci identiﬁed included those encoding two
glycosyltransferases, one of which contains a 50CCAA repeat, the
ﬁrst occasion for Hi where this particular SSR unit sequence has
been associated with genes encoding proteins of any function
other than hemoglobin and hemoglobin–haptoglobin binding.
Although tetranucleotide SSRs are the most frequent mediators
of phase variation in Hi, other SSRs may play a role in mediating
phase variation, particularly in strains such as F3031 and F3043.
This study has identiﬁed a number of novel mononucleotide,
dinucleotide, pentanucleotide, heptanucleotide, and octanucleo-
tide SSRs as potential mediators of phase variation. Mononucleo-
tide SSRs have not previously been described as frequent
mediators of phase variation in Hi, in contrast to other bacterial
species such as N. meningitidis. There is only one report in the
literature of mononucleotide SSRs potentially mediating phase
variation in Hi; a G10 SSR is suspected to mediate phase variation
of the iga gene, AF522258, in Hi biogroup aegyptius strain HK266
(Kilian et al., 2002). However, the distribution of the mononucleo-
tide SSR loci identiﬁed in this study suggests that there may be
some strain-dependent differences in the use of mononucleotide
SSR tomediate phase variation. The potentialmononucleotide SSR-
mediated phase variable genes identiﬁed include those encoding
factors associated with virulence such as glycosyltransferases,
type-I restriction modiﬁcation systems, haemagglutinins, YadA
domain containing proteins (Cotter et al., 2005b; Koretke et al.,
P.M. Power et al. / Infection, Genetics and Evolution 9 (2009) 216–228 2272006), pilin and a Fe–S cluster assembly scaffold protein (see
Table 7). A number of the genes where phase variation is
potentially mediated by homopolymeric tracts are phase variable
by other mechanisms in other strains. For example, hifA and hifB
expression is usually mediated by a dinucleotide SSR (van Ham
et al., 1993). Similarly, the expression of YadA-domain containing
proteins is potentially mediated by tetranucleotide SSRs in some
loci identiﬁed in this study and by mononucleotide SSRs in other
loci whilst the expression of the hmw1A and hmw2A genes is
potentiallymediated by upstreamheptanucleotide, octanucleotide
or nonanucleotide SSRs in different strains.
Differences in the classes of SSRswhichmediate phase variation
between species, or even different strains of one species, may be
determined by inter species/inter strain differences in DNA
metabolism as the efﬁciencywithwhich different types of slippage
intermediates are recognised and repaired is reliant upon the
complement of DNA repairmechanisms in the given strain/species.
Investigation of the molecular basis of these differences will be
aided by the availability of full genome sequences in conjunction
with experimental assays.
The strains examined in this study were isolated in the United
Kingdom (one strain), Brazil (two strains) and the United States of
America (13 strains). A majority of the novel SSRs identiﬁed were
in the F3031 and F3043 genome sequences (the Brazilian strains)
and it remains unknown whether the population/geographical
structure of Hi strains may be a signiﬁcant factor in determining
the complement of SSR within a strain: until the population
structure of Hi is better understood it is difﬁcult to predict the size
of the SSR pan-genome and its potential role in mediating phase
variation. In the strains studied, with the exception of F3031 and
F3043, there were no associations between the ability to cause
disease or commensal infection in the strains and the complement
of potential phase variable mediating SSRs. For each strain, the
contribution of the number and complement of phase variable
genes to the probability of pathogenic potential remains unknown.
In conclusion, this study has reafﬁrmed the primacy of tetra-
nucleotide SSRs as mediators of phase variation in Hi and has
characterised and compared 28 tetranucleotide SSR loci (9 of them
previouslyunreported)across16strains.Additionally, this studyhas
identiﬁed a number of previously unrecognised mononucleotide,
dinucleotide, pentanucleotide, heptanucleotide, and octanucleotide
SSRs as potential mediators of phase variation that will be the focus
of future research efforts. Thus, the utility of whole genome
sequences in the investigation of the biology of pathogenic bacteria
has been conﬁrmed and, further, the analysis of multiple genomes
has revealed non-intuitive subtleties in the population structure
concerning the distribution of SSRs across the Hi pan-genome.
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